2015
DOI: 10.1155/2015/359301
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug‐Resistant Tuberculosis: Treatment and Outcomes of 93 Patients

Abstract: MDR TB can be controlled with the available anti-TB drugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 23 publications
(24 reference statements)
0
6
0
1
Order By: Relevance
“…The TB program at WPHC, located in Toronto, Ontario, is recognized as a referral centre for drug-resistant TB, and sees the majority of MDR-TB cases in the province (84% between 2000 and 2011) (9). All patients who were diagnosed with TB and treated at WPHC between January 2010 and December 2016 were included in this retrospective cohort study.…”
Section: Methodsmentioning
confidence: 99%
“…The TB program at WPHC, located in Toronto, Ontario, is recognized as a referral centre for drug-resistant TB, and sees the majority of MDR-TB cases in the province (84% between 2000 and 2011) (9). All patients who were diagnosed with TB and treated at WPHC between January 2010 and December 2016 were included in this retrospective cohort study.…”
Section: Methodsmentioning
confidence: 99%
“…32,33 Reports have suggested treatment success rates greater than 80% with individualised treatment in countries such as the Netherlands, Canada, and South Korea. [34][35][36] Indeed, there is potential for treatment to be further individualised on the basis of the results of detailed therapeutic drug monitoring in these settings. 37 Individualisation is also often needed because of drug toxicities and drug-drug interactions, particularly when comorbidities, such as HIV infection and diabetes, are present.…”
Section: Benefits Of Individualised Treatmentmentioning
confidence: 99%
“…Situé à Toronto, en Ontario, le CSWP est un centre de référence pour la prise en charge de la TB pharmacorésistante, et traite la majorité des cas de TB-MR de la province (84 % entre 2000 et 2011) (9). Tous les patients chez qui on a diagnostiqué la TB et qui ont été traités au CSWP entre janvier 2010 et décembre 2016 ont été pris en compte dans cette étude de cohorte rétrospective.…”
Section: Méthodesunclassified